全文获取类型
收费全文 | 27653篇 |
免费 | 2329篇 |
国内免费 | 981篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 548篇 |
妇产科学 | 279篇 |
基础医学 | 8651篇 |
口腔科学 | 411篇 |
临床医学 | 2381篇 |
内科学 | 4834篇 |
皮肤病学 | 886篇 |
神经病学 | 818篇 |
特种医学 | 278篇 |
外国民族医学 | 12篇 |
外科学 | 1721篇 |
综合类 | 3803篇 |
现状与发展 | 5篇 |
预防医学 | 918篇 |
眼科学 | 207篇 |
药学 | 1481篇 |
1篇 | |
中国医学 | 451篇 |
肿瘤学 | 3147篇 |
出版年
2024年 | 39篇 |
2023年 | 255篇 |
2022年 | 475篇 |
2021年 | 682篇 |
2020年 | 608篇 |
2019年 | 698篇 |
2018年 | 706篇 |
2017年 | 691篇 |
2016年 | 780篇 |
2015年 | 1019篇 |
2014年 | 1398篇 |
2013年 | 1707篇 |
2012年 | 1448篇 |
2011年 | 2021篇 |
2010年 | 1713篇 |
2009年 | 1869篇 |
2008年 | 1671篇 |
2007年 | 1656篇 |
2006年 | 1568篇 |
2005年 | 1413篇 |
2004年 | 1265篇 |
2003年 | 1141篇 |
2002年 | 953篇 |
2001年 | 769篇 |
2000年 | 664篇 |
1999年 | 581篇 |
1998年 | 554篇 |
1997年 | 421篇 |
1996年 | 424篇 |
1995年 | 431篇 |
1994年 | 340篇 |
1993年 | 254篇 |
1992年 | 139篇 |
1991年 | 131篇 |
1990年 | 67篇 |
1989年 | 39篇 |
1988年 | 21篇 |
1985年 | 14篇 |
1984年 | 38篇 |
1983年 | 24篇 |
1982年 | 39篇 |
1981年 | 35篇 |
1980年 | 31篇 |
1979年 | 28篇 |
1978年 | 23篇 |
1977年 | 23篇 |
1976年 | 25篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1973年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
41.
Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis 总被引:2,自引:0,他引:2
L. Lombardo A. Capaldi G. Poccardi P. Vineis 《International Journal of Clinical & Laboratory Research》1995,25(3):153-156
Summary Immunological disturbances with impairment of immune function and a higher incidence of lymphoproliferative disorders and
other malignancies have been described in liver cirrhosis patients. To investigate the pathogenetic mechanism(s) involved
in such associated we looked for a possible imbalance in peripheral blood T-lymphocyte subpopulations in patients with liver
cirrhosis of differing severity. Immunophenotyping and counts of peripheral blood T-lymphocyte subpopulations were carried
out using monoclonal antibodies conjugated with different fluorochromes in 31 consecutive cirrhotic patients and 23 matched
healthy volunteers. Univariate and multivariate analyses of lymphocyte phenotype counts were performed and odds ratios were
computed. Statistically significant associations, according to both univariate and multivariate analyses, were found between
case/control status and mean CD3 and CD4 T-lymphocyte counts (P<0.0001). A strong correlation was found between the Pugh’s index and CD3 and CD4 lymphocyte counts, with a clear reduction
of these phenotypes with increasing liver cirrhosis. Median CD3 and CD4 values were 2,283 and 1,329/μl respectively among
controls and 896, 801, and 492/μl and 515, 514, and 307/μl, respectively in categories A, B, and C of Pugh’s classification.
Very high odds ratios were found using the median values of CD3 and CD4 as a threshold. There was a statistically significant
decrease for each of the T-cell phenotypes studied (CD2, CD3, CD4, CD8, CD16, CD19, CD20, CD56, CD57) between patients and
controls (P<0.0001). The progressive and severity-related decrease in mean peripheral blood CD3 and CD4 counts in liver cirrhosis suggests
a progressive impairment of protective immune function and may be a factor facilitating malignancy in cirrhotic patients. 相似文献
42.
CD5 is expressed on thymocytes, all mature T cells, and a subset of mature B cells, and probably contributes to T-cell–B-cell adhesion. We assessed whether CD5-crosslinking by mAb augments T-cell stimulation. Plate-bound anti-CD5 or anti-CD3 mAb alone had no effect on any of the assessed activation parameters of resting T cells. However, concomitant signaling through both CD5 and CD3 by plate-bound antibodies resulted in marked increases in T-cell surface CD69 expression and T-cell metabolism, as assessed by the T cell's ability to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) to formazen. In addition, simultaneous cross-linking of CD5 and CD3 caused a significant (p < 0.001) increase in phosphatidylinositol hydrolysis in resting T cells compared to stimulation with anti-CD3 mAb alone or anti-CD3 mAb plus anti-CD5 isotype control antibody. These results indicate that CD5 augments signaling through CD3 and consequently functions as a costimulatory molecule for resting T cells. 相似文献
43.
Inhibition of HIV-1 by modification of a host membrane protease 总被引:3,自引:0,他引:3
Bristow Cindy L.; Fiscus Susan A.; Flood Patrick M.; Arnold Roland R. 《International immunology》1995,7(2):239-249
While it is clear that CD4 Is the receptor for the gp120 envelopeprotein of HIV-1, substantial evidence suggests that other hostcell proteins are required for successful membrane fusion. Studieswere initiated to examine the potential for a protein receptorwhich has an elastase-like character to participate in fusionof HIV-1 with permissive host cells. A synthetic elastase inhibitorwas shown to significantly reduce HIV-1 infectivity when presentduring, but not after, the initial contact between virus andcells. A human T cell elastase-like membrane component was purifiedand shown to be lipid-associated. By competitive Inhibition,the purified protein was shown to bind gp160 within the HIV-1fusion domain. The binding parameters of whole T cell membraneextract, with a hydrophobic pentapeptide representative of thefusion domain, suggested an elastase-like protein is the single,secondary T cell receptor for HIV-1 (K = 1x103 M–1). Thepentapeptide interacted with porcine and human (epithelial andpolymorphonuclear leukocyte), but not murine, elastase isoforms,suggesting its participation In the permissiveness of host cellsto infection. 相似文献
44.
Potent inhibition of HIV-1 entry by (s4dU)35 总被引:2,自引:0,他引:2
Horváth A Tokés S Hartman T Watson K Turpin JA Buckheit RW Sebestyén Z Szöllosi J Benko I Bardos TJ Dunn JA Fésüs L Tóth FD Aradi J 《Virology》2005,334(2):214-223
45.
Peter Lane Corinne Burdet Fiona McConnell Antonio Lanzavecchia Elisabetta Padovan 《European journal of immunology》1995,25(6):1788-1793
We report the capacity of CD40 ligand (CD40L)-negative T cell clones to activate human B cells. CD40L-negative T cells induce a level of B cell proliferation 10–20% of that seen with normal T cells. The signal provided by the negative clones is synergistic with that derived from a CD40L transfectant, and restores B cell proliferation to normal levels, showing that CD40L-negative T cell clones are not inherently inhibitory for B cells. Although their capacity to induce proliferation was much reduced, CD40L-negative T cell clones were still strong inducers of B cell differentiation to plasma cells. This differentiation to plasma cells was inhibited by a CD40L transfectant. The data are discussed with regard to the normal in vivo mechanism for maintaining B cell memory and memory antibody responses to T-dependent antigens. 相似文献
46.
Abuye C Tsegaye A West CE Versloot P Sanders EJ Wolday D Hamann D De Wit TF Fontanet AL 《Journal of clinical immunology》2005,25(2):127-133
To study the determinants of CD4% and CD4 counts among HIV-negative Ethiopians, and to identify factors susceptible to explain the low CD4 counts observed among Ethiopian subjects. Cohort studies among factory workers in Akaki and Wonji, Ethiopia. Clinical and laboratory examinations, including determination of HIV serological status and T-cell subsets, were performed during follow-up visits every six months. In addition, micronutrients (retinol, carotenoids, tocopherol, transferrin receptor, and selenium) plasma concentrations were determined in a subset of 38 HIV-positive and 121 HIV-negative participants. HIV-negative participants with at least one CD4 count measurement were 157 females in Akaki, 203 males in Akaki, and 712 males in Wonji. CD4 counts were independently and positively associated with body mass index (through an increase in lymphocyte counts), female gender (through an increase in CD4%), cigarette smoking (through an increase in CD4%), khat chewing (through an increase in both lymphocyte counts and CD4%), and Akaki study site (through a large increase in lymphocyte counts compensating a decrease in CD4%). Intestinal parasitic infections were not associated with CD4% or CD4 counts. Retinol, carotenoids, and -tocopherol plasma concentrations decreased with HIV infection and advancing immunosuppression, but were not associated with CD4 counts among HIV-negative subjects. Low body mass index among Ethiopians may have contributed to their overall low CD4 counts. Other factors remain to be elucidated. 相似文献
47.
Yang JQ Chun T Liu H Hong S Bui H Van Kaer L Wang CR Singh RR 《European journal of immunology》2004,34(6):1723-1732
Mechanisms responsible for the development of autoimmune skin disease in humans and animal models with lupus remain poorly understood. In this study, we have investigated the role of CD1d, an antigen-presenting molecule known to activate natural killer T cells, in the development of inflammatory dermatitis in lupus-susceptible MRL-lpr/lpr mice. In particular, we have established MRL-lpr/lpr mice carrying a germ-line deletion of the CD1d genes. We demonstrate that CD1d-deficient MRL-lpr/lpr mice, as compared with wild-type littermates, have more frequent and more severe skin disease, with increased local infiltration with mast cells, lymphocytes and dendritic cells, including Langerhans cells. CD1d-deficient MRL-lpr/lpr mice had increased prevalence of CD4(+) T cells in the spleen and liver and of TCR alpha beta (+)B220(+) cells in lymph nodes. Furthermore, CD1d deficiency was associated with decreased T cell production of type 2 cytokines and increased or unchanged type 1 cytokines. These findings indicate a regulatory role of CD1d in inflammatory dermatitis. Understanding the mechanisms by which CD1d deficiency results in splenic T cell expansion and cytokine alterations, with increased dermal infiltration of dendritic cells and lymphocytes in MRL-lpr/lpr mice, will have implications for the pathogenesis of inflammatory skin diseases. 相似文献
48.
Stebbing J Bower M Gazzard B Wildfire A Pandha H Dalgleish A Spicer J 《Clinical and experimental immunology》2004,138(2):312-316
Despite advances in our understanding of tumour immunology there is no therapy of proven survival benefit for advanced melanoma. Nevertheless, disease progression is slow in a small proportion of patients with metastatic melanoma, suggesting a contribution to outcome from host factors. Recent data have indicated the importance of the heat shock protein receptor CD91 in immune responses to, and progression of, infectious disease. Here we investigate the relationship between CD91 expression and outcome in malignancy. Rare melanoma patients were recruited with advanced disease that was progressing unusually slowly. CD91 expression on their monocytes was compared with control patients with more typical rapidly advancing metastatic disease. Th1 and Th2 cytokines, as well as innate and adaptive immune subsets, were also measured in the two groups. A significant increase in median CD91 expression levels was observed in slow progressors (P = 0.006). There were no differences in other immune subset markers or inflammatory cytokines. The ability of CD91 to internalize and cross-present tumour antigens through the major histocompatibility complex class I pathway may maintain CD8-positive cytotoxic T cell responses and contribute to slow progression of advanced melanoma. 相似文献
49.
β-Endorphin stimulates phytohemagglutinin-induced production of IL-4 and does not modify the production of γ-IFN in nonfractionated
leukocyte suspension. In a culture of purified CD4+ T-cells, β-endorphin does not modify the levels of IL-4 and γ-IFN, but stimulates the production of IL-4 and inhibits γ-IFN
production after addition of monocytes to CD4+ lymphocytes. Stimulation of IL-4 synthesis by β-endorphin is mediated by the cycloxygenase cycle products. Hence, β-endorphin
shifts T-helper polarization towards Th2 cells with subsequent predominance of the humoral form of the immune response.
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 146, No. 10, pp. 427-430, October, 2008 相似文献
50.
Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells 总被引:3,自引:0,他引:3
Belov L Huang P Chrisp JS Mulligan SP Christopherson RI 《Journal of immunological methods》2005,305(1):10-19
We have developed a microarray (DotScan) that enables rapid immunophenotyping and classification of leukaemias and lymphomas by measuring the capture of cells by immobilized dots of 82 CD antibodies [Belov, L., de la Vega, O., dos Remedios, C.G., Mulligan, S.P., 2001. Immunophenotyping of leukemia using a cluster of differentiation antibody microarray. Cancer Res. 61, 4483; Belov, L., Huang, P., Barber, N., Mulligan, S.P., Christopherson, R.I., 2003. Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics 3, 2147]. The DotScan technology has been used to investigate the properties of 498 new antibodies submitted to the HLDA8 Workshop. These antibodies have been applied as 10 nl dots to a film of nitrocellulose on a microscope slide to make an HLDA8 microarray. After blocking the remaining nitrocellulose surface, individual arrays were incubated with each of 7 cell types from a human leukaemia cell panel consisting of three cell lines, CCRF-CEM (a T-cell acute lymphocytic leukaemia), MEC-1 (derived from B-cell chronic lymphocytic leukaemia) and HL-60 (a promyelocytic leukaemia), and four leukaemias from patients: a T-cell prolymphocytic leukaemia, a B-cell chronic lymphocytic leukaemia, and two acute myeloid leukaemias. Leukaemia cells were captured by those immobilized antibodies for which they expressed the corresponding surface molecule. Unbound cells were gently washed off, bound cells were fixed to the arrays and dot patterns were recorded using a DotScan array reader and quantified using DotScan data analysis software. The data obtained show the unique expression profiles of the 7 cell types in the leukaemia cell panel obtained with the DotScan microarray, and the differential capture patterns for these 7 cell types screened against the 498 antibodies in the HLDA8 microarray constructed for this study. 相似文献